drugset
drugset / Trial / NCT07126171

A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever

NCT07126171 ↗

Not yet recruiting 400 enrolled Jiangsu Kanion Pharmaceutical Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy and safety of Reduning Injection in the treatment of chikungunya fever

Timeline

Start
2025-08-28
Primary completion
2025-11-26
Completion
2026-02-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Reduning injection Unknown 20 ml Intravenous

Indications

chikungunya